David Parkin : Citation Profile


Are you David Parkin?

Office of Health Economics (50% share)
City University (50% share)

11

H index

13

i10 index

590

Citations

RESEARCH PRODUCTION:

25

Articles

12

Papers

1

Books

RESEARCH ACTIVITY:

   35 years (1985 - 2020). See details.
   Cites by year: 16
   Journals where David Parkin has often published
   Relations with other researchers
   Recent citing documents: 4.    Total self citations: 11 (1.83 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/ppa171
   Updated: 2024-01-16    RAS profile: 2023-06-08    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Devlin, Nancy (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with David Parkin.

Is cited by:

Devlin, Nancy (36)

Shah, Koonal (13)

Siciliani, Luigi (10)

Brouwer, Werner (10)

Karlsberg Schaffer, Sarah (8)

Karlsberg, Sarah (8)

Di Matteo, Livio (8)

Brazier, John (8)

Blankart, Katharina (7)

Costa-Font, Joan (7)

Leidl, Reiner (6)

Cites to:

Devlin, Nancy (25)

Culyer, Anthony (8)

Street, Andrew (8)

Brazier, John (7)

Rice, Nigel (7)

Appleby, John (5)

Daidone, Silvio (4)

Roberts, Jennifer (4)

Simar, Leopold (3)

Wilson, Paul (3)

Tsuchiya, Aki (3)

Main data


Where David Parkin has published?


Journals with more than one article published# docs
Health Economics10
Health Policy4
Social Science & Medicine3
Medical Decision Making3

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York2

Recent works citing David Parkin (2024 and 2023)


YearTitle of citing document
2023Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries. (2023). Gentilini, Arianna ; Visintin, Erica ; Kanavos, Panos. In: Social Science & Medicine. RePEc:eee:socmed:v:331:y:2023:i:c:s0277953623004021.

Full description at Econpapers || Download paper

2023Economic Evaluation under Ambiguity and Structural Uncertainties. (2023). Andrews, Brendon. In: Working Papers. RePEc:ris:albaec:2023_009.

Full description at Econpapers || Download paper

2023Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7.

Full description at Econpapers || Download paper

2023Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries. (2023). Efthymiadou, Olina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01526-x.

Full description at Econpapers || Download paper

Works by David Parkin:


YearTitleTypeCited
2011Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers.
[Full Text][Citation analysis]
paper21
2013TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK?ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 21
article
2013The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers.
[Full Text][Citation analysis]
paper29
2015The Influence of Cost?Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 29
article
1991Chiropody and the QALY: a case study in assigning categories of disability and distress to patients In: Health Policy.
[Full Text][Citation analysis]
article5
1995Clearing the fog on the Tyne: programme budgeting in Newcastle and North Tyneside Health Authority In: Health Policy.
[Full Text][Citation analysis]
article7
1997Less fog on the Tyne? Programme budgeting in Newcastle and North Tyneside In: Health Policy.
[Full Text][Citation analysis]
article3
2009Searching for cost effectiveness thresholds in the NHS In: Health Policy.
[Full Text][Citation analysis]
article31
1987Aggregate health care expenditures and national income : Is health care a luxury good? In: Journal of Health Economics.
[Full Text][Citation analysis]
article148
1985The demand for dental care: An assessment In: Social Science & Medicine.
[Full Text][Citation analysis]
article4
2019Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study In: Social Science & Medicine.
[Full Text][Citation analysis]
article3
2004Use of a visual analogue scale in a daily patient diary: modelling cross-sectional time-series data on health-related quality of life In: Social Science & Medicine.
[Full Text][Citation analysis]
article4
2014Towards Earlier Discharge, Better Outcomes, Lower Cost: Stroke Rehabilitation in Ireland In: Research Series.
[Full Text][Citation analysis]
book1
2000Costs and Quality of Life in Multiple Sclerosis. A Cross-Sectional Observational Study in the UK In: SSE/EFI Working Paper Series in Economics and Finance.
[Full Text][Citation analysis]
paper19
2009Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science.
[Full Text][Citation analysis]
article33
2013The Influence of Cost-effectiveness and Other Factors on NICE Decisions In: Research Paper.
[Full Text][Citation analysis]
paper7
2012Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Paper.
[Full Text][Citation analysis]
paper2
2011Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Paper.
[Full Text][Citation analysis]
paper3
2014What Determines the Shape of an EQ-5D Index Distribution? In: Research Paper.
[Full Text][Citation analysis]
paper7
2016The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Paper.
[Full Text][Citation analysis]
paper0
2018New Methods for Analysing the Distribution of EQ-5D Observations In: Research Paper.
[Full Text][Citation analysis]
paper2
2019Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Paper.
[Full Text][Citation analysis]
paper0
2020Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? In: Research Paper.
[Full Text][Citation analysis]
paper2
1989Comparing Health Service Efficiency Across Countries. In: Oxford Review of Economic Policy.
[Citation analysis]
article1
2002Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices In: MPRA Paper.
[Full Text][Citation analysis]
paper16
2010Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? In: Medical Decision Making.
[Full Text][Citation analysis]
article8
2016What Determines the Shape of an EQ-5D Index Distribution? In: Medical Decision Making.
[Full Text][Citation analysis]
article2
2020Using EQ-5D Data to Measure Hospital Performance: Are General Population Values Distorting Patients’ Choices? In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2003A single European currency for EQ-5D health states In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article11
1997Measuring production efficiency of acute hospitals in Scotland, 1991-94: validity issues in data envelopment analysis In: Applied Economics.
[Full Text][Citation analysis]
article39
2002Recognising diversity in public preferences: the use of preference sub?groups in cost?effectiveness analysis. A response to Sculpher and Gafni In: Health Economics.
[Full Text][Citation analysis]
article6
2004Does NICE have a cost?effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics.
[Full Text][Citation analysis]
article114
2006Is there a case for using visual analogue scale valuations in cost?utility analysis? In: Health Economics.
[Full Text][Citation analysis]
article33
2007‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics.
[Full Text][Citation analysis]
article0
2010Patient?reported outcome measures in the NHS: new methods for analysing and reporting EQ?5D data In: Health Economics.
[Full Text][Citation analysis]
article10
2015INTER?PROVIDER COMPARISON OF PATIENT?REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics.
[Full Text][Citation analysis]
article2
1995Investigating hospital efficiency in the new NHS: The role of the translog cost function In: Health Economics.
[Full Text][Citation analysis]
article14
1999Non? and semi?parametric estimation of age and time heterogeneity in repeated cross?sections: an application to self?reported morbidity and general practitioner utilization1 In: Health Economics.
[Full Text][Citation analysis]
article3

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team